ArticleFrontiers in allergy2026

Mepolizumab reduces systemic corticosteroid-related toxicities and healthcare burden in patients with eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome: a retrospective database study.

Thanai Pongdee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.